ORESHACK KURT 4
4 · MARAVAI LIFESCIENCES HOLDINGS, INC. · Filed Jan 27, 2022
Insider Transaction Report
Form 4
ORESHACK KURT
General Counsel
Transactions
- Award
Class A Common Stock
2021-10-31$22.95/sh+542$12,439→ 8,537 total - Award
Class A Common Stock
2021-04-30$22.95/sh+495$11,360→ 7,995 total - Award
Class A Common Stock
2022-01-25+17,000→ 25,537 total - Award
Employee Stock Option (Right to Buy)
2022-01-25+31,500→ 31,500 totalExercise: $26.32Exp: 2032-01-25→ Class A Common Stock (31,500 underlying)
Footnotes (3)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,037 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c).
- [F2]Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of February 15, 2023, February 15, 2024, and February 15, 2025, subject to the Reporting Person's continued employment with the Issuer.
- [F3]Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on March 15, 2022 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.